Rankings
▼
Calendar
VCEL
Vericel Corporation
$2B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$36M
+4.4% YoY
Gross Profit
$23M
65.0% margin
Operating Income
-$7M
-20.2% margin
Net Income
-$7M
-19.7% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
-24.2%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$387,000
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$240M
Total Liabilities
$68M
Stockholders' Equity
$172M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$36M
$35M
+4.4%
Gross Profit
$23M
$23M
+2.0%
Operating Income
-$7M
-$3M
-120.1%
Net Income
-$7M
-$3M
-115.6%
Revenue Segments
MACI Implants And Kits Member
$26M
100%
← FY 2022
All Quarters
Q2 2022 →
VCEL Q1 2022 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena